Mini-review: Lactoferrin: a bioinspired, anti-biofilm therapeutic
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Medically relevant biofilms have gained a significant level of interest, in part because of the epidemic rise in obesity and an aging population in the developed world. The associated comorbidities of chronic wounds such as pressure ulcers, venous leg ulcers, and diabetic foot wounds remain recalcitrant to the therapies available currently. Development of chronicity in the wound is due primarily to an inability to complete the wound healing process owing to the presence of a bioburden, specifically bacterial biofilms. New therapies are clearly needed which specifically target biofilms. Lactoferrin is a multifaceted molecule of the innate immune system found primarily in milk. While further investigation is warranted to elucidate mechanisms of action, in vitro analyses of lactoferrin and its derivatives have demonstrated that these complex molecules are structurally and functionally well suited to address the heterogeneity of bacterial biofilms. In addition, use of lactoferrin and its derivatives has proven promising in the clinic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antimicrobial peptides of multicellular organisms
Zasloff, M. (2002) · Nature · doi:10.1038/415389a · Cited by 8,457 · cited 1×
“Antimicrobial peptides such as lactoferrin and its derivatives have been of great interest as an alternative class of antibiotics (Zasloff 2002).”
Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms
Donlan, R. M., & Costerton, J. W. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.167-193.2002 · Cited by 6,644
Bacterial Biofilms in Nature and Disease
Costerton, J. W., Cheng, K. J., Geesey, G. G., Ladd, T. I., Nickel, J. C., Dasgupta, M., & Marrie, T. J. (1987) · Annual Review of Microbiology · doi:10.1146/annurev.mi.41.100187.002251 · Cited by 3,145
Siderophore-Based Iron Acquisition and Pathogen Control
Miethke, M., & Marahiel, M. A. (2007) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00012-07 · Cited by 1,774
James, G. A., Swogger, E., Wolcott, R., Pulcini, E. D., Secor, P., Sestrich, J., Costerton, J. W., & Stewart, P. S. (2008) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2007.00321.x · Cited by 1,543 · cited 3×
“Over the course of a lifetime, up to 15% of diabetics can expect to have at least one amputation of an extremity due to an untreatable chronic wound (James et al. 2008); a problem that has been compounded by the development of antibiotic resistance and the absence of new effective methods of treatment (Boucher et al.”
Bacterial adhesion: seen any good biofilms lately
Dunne, W. M. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.155-166.2002 · Cited by 1,516
A component of innate immunity prevents bacterial biofilm development
Singh, P. K., Parsek, M. R., Greenberg, E. P., & Welsh, M. J. (2002) · Nature · doi:10.1038/417552a · Cited by 1,026 · cited 5×
“aeruginosa demonstrated that lactoferrin inhibits biofilm formation and disrupts existing biofilms either by preventing lectin-dependent bacterial adhesion or stimulating bacterial motility (Singh et al. 2002; LesmanMovshovich et al. 2003).”
InfluentialIron and Pseudomonas aeruginosa biofilm formation
Banin, E., Vasil, M. L., & Greenberg, E. P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504266102 · Cited by 801
LACTOFERRIN, AN IRON-BINBING PROTEIN NI NEUTROPHILIC LEUKOCYTES
Masson, P. L., Heremans, J. F., & Schonne, E. (1969) · The Journal of Experimental Medicine · doi:10.1084/jem.130.3.643 · Cited by 700
Human Toll-like receptor 4 recognizes host-specific LPS modifications
Hajjar, A. M., Ernst, R. K., Tsai, J. H., Wilson, C. B., & Miller, S. I. (2002) · Nature Immunology · doi:10.1038/ni777 · Cited by 579
Biofilm material properties as related to shear-induced deformation and detachment phenomena
Stoodley, P., Cargo, R., Rupp, C. J., Wilson, S., & Klapper, I. (2002) · Journal of Industrial Microbiology and Biotechnology · doi:10.1038/sj.jim.7000282 · Cited by 549 · cited 2×
“However, these cells appear unable to engulf the bacteria and exhibit ‘frustrated phagocytosis’ in which the phagocytic cell continuously deposits pro-inflammatory proteins and small molecules into the environment resulting in secondary damage to the host tissue (Stoodley et al. 2002; Archer et al. 2011).”
Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment
Yamauchi, K., Tomita, M., Giehl, T. J., & Ellison, R. T. (1993) · Infection and Immunity · doi:10.1128/iai.61.2.719-728.1993 · Cited by 500 · cited 1×
“…demonstrated to have anti-fungal, anti-viral, anti-microbial, anti-tumor characteristics as well as the ability to modulate both the inflammatory response and adaptive immunity (Bellamy, Takase, Yamauchi et al. 1992; Yamauchi et al. 1993; Brock 1995; Wakabayashi et al. 1999; Andersen et al. 2001).”
Microscopic and physiologic evidence for biofilm-associated wound colonization in vivo
Davis, S. C., Ricotti, C., Cazzaniga, A., Welsh, E., Eaglstein, W. H., & Mertz, P. M. (2008) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2007.00303.x · Cited by 393 · cited 1×
“It has been well demonstrated that establishment of a bacterial biofilm in the wound is the major reason for treatment failure of acute wounds and development of chronic, non-healing wounds (Harrison-Balestra et al. 2003; Bjarnsholt et al. 2008; Davis et al. 2008; James et al. 2008).”
Bellamy, W., Wakabayashi, H., Takase, M., Kawase, K., Shimamura, S., & Tomita, M. (1993) · Medical Microbiology and Immunology · doi:10.1007/bf00189377 · Cited by 219 · cited 2×
“Lactoferricin therapy is effective against infections of the urinary tract and lactoferrin has been used as an oral treatment for irritable bowel syndrome with a normalizing effect on the gut microbiome (Bellamy et al. 1993; Zagulski et al. 1998; Ha & Kornbluth 2010; Hu et al. 2012; Ochoa et al. 2012).”
Fazli, M., Bjarnsholt, T., Kirketerp‐Møller, K., Jørgensen, A., Andersen, C. B., Givskov, M., & Tolker‐Nielsen, T. (2011) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2011.00681.x · Cited by 155 · cited 2×
“Although neutrophils appear to be recruited to the chronic wound site in disproportionate numbers (Fazli et al. 2011), whether degranulation continues to occur and in what concentrations the contents of the granules, including lactoferrin, are released into the environment remains to be established (Table 2).”
Beasley, F. C., Marolda, C. L., Cheung, J., Buac, S., & Heinrichs, D. E. (2011) · Infection and Immunity · doi:10.1128/iai.00117-11 · Cited by 151 · cited 1×
“Staphylococcus aureus utilizes an ABC transporter for exportation of siderophores (Poole et al. 1993; Vettoretti et al. 2009; Grigg et al. 2010; Beasley et al. 2011).”
Baker, H. M., & Baker, E. N. (2012) · Biochemistry and Cell Biology · doi:10.1139/o11-071 · Cited by 130
Wakabayashi, H., Abe, S., Okutomi, T., Tansho, S., Kawase, K., & Yamaguchi, H. (1996) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1996.tb01147.x · Cited by 116 · cited 2×
“In addition, lactoferrin and its peptide derivatives have been used in combination with anti-fungal agents against clinically relevant Candida species in vitro (Wakabayashi et al. 1996; Lupetti et al. 2003; Naidu et al. 2004; Venkatesh & Rong 2008; Harris & Coote 2010).”
Discovery and development of a synthetic peptide derived from lactoferrin for clinical use
Brouwer, C. P. J. M., Rahman, M., & Welling, M. M. (2011) · Peptides · doi:10.1016/j.peptides.2011.07.017 · Cited by 90 · cited 1×
“In treating systemic or internal infections, lactoferrin and its derivatives have promise in part because these antimicrobial peptides retain efficacy when administered through various routes (Brouwer et al. 2011).”
Cited by
Chronic wound infections: the role of Pseudomonas aeruginosa and Staphylococcus aureus
Serra, R., Grande, R., Butrico, L., Rossi, A., Settimio, U. F., Caroleo, B., Amato, B., Gallelli, L., & de Franciscis, S. (2015) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.1023291 · Cited by 648
Approaches to Dispersing Medical Biofilms
Fleming, D., & Rumbaugh, K. (2017) · Microorganisms · doi:10.3390/microorganisms5020015 · Cited by 329
The Prevalence and Control of Bacillus and Related Spore-Forming Bacteria in the Dairy Industry
Gopal, N., Hill, C., Ross, P. R., Beresford, T. P., Fenelon, M. A., & Cotter, P. D. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01418 · Cited by 316
Anti-biofilm Activity as a Health Issue
Miquel, S., Lagrafeuille, R., Souweine, B., & Forestier, C. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00592 · Cited by 225
“Bioinspired anti-biofilm molecules can be isolated from eukaryotes, such as the lactoferrin (Ammons and Copié, 2013), but most are derived from microbial phenomena occurring within the biofilms themselves.”
BackgroundBrożyna, M., Dudek, B., Kozłowska, W., Malec, K., Paleczny, J., Detyna, J., Fabianowska-Majewska, K., & Junka, A. (2024) · Scientific Reports · doi:10.1038/s41598-024-52424-6 · Cited by 24
Metadata
- Authors
- Ammons, M. C., & Copié, V.
- Venue
- Biofouling
- Publisher
- Informa UK Limited
- Published
- 2013-04
- Volume
- 29
- Issue
- 4
- Pages
- 443-455
- ISSN
- 0892-7014 (ISSN-L)
- 1029-2454
- OpenAlex
- W2073029391
- Cited by
- 141
- References
- 19
- FWCI
- 0.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.